Oklo Reaches Criticality Milestone, Yet Valuation Questions Persist

Oklo (OKLO) has achieved first criticality at its Groves low-power reactor in Texas, marking progress for its Aurora modular reactor strategy. A Simply Wall St analysis argues the stock is undervalued, citing a fair value around $80.55 per share versus a recent price near $43, and highlighting long-term electricity contracts and potential AI/data-center demand as revenue drivers. NRC approval of the Principal Design Criteria reduces some regulatory uncertainty, but no commercial plants are operating yet and full NRC licensing remains unresolved, making the valuation highly dependent on aggressive growth assumptions and exposing the stock to meaningful regulatory risk if progress slows.